The EMIT® II Plus Cocaine Metabolite Assay is intended for the qualitative and semiquantitative determination of benzoylecgonine in human urine, at a cutoff value of 150 ng/mL or 300 ng/mL. The SAMHSA initial test cutoff level is 150 ng/mL.
Cocaine is a central nervous system stimulant that is extracted from the coca plant. Cocaine base can be smoked in a form that is commonly known as “crack.” Cocaine is rapidly absorbed, especially when smoked, which is why the major metabolite, benzoylecgonine, is used for immunoassay drug screening.
The EMIT II Plus Cocaine Metabolite Assay provides:
Applications are available for the Viva-Jr®, Viva-E®, Viva-ProE®, V-Twin® drug testing systems and AU® Series analyzers.
Assay Principle | Homogeneous Enzyme Multiplied Immonoassay (EMIT) |
Cut-off | 150 ng/mL or 300 ng/mL |
Sample | Urine |
Reagent Stability | Unopened: until expiration date. Onboard instrument: up to 4 weeks |
Calibration Frequency | As indicated by control results |